PyInvesting

Market research

RHT.AU Resonance Health Limited

AU AUD Healthcare

Latest close

0.08 —

As of Nov 20, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
50M
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
1.0

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Resonance Health Limited is currently in a long term downtrend where the price is trading 3.4% below its 200 day moving average.

From a valuation standpoint, the stock is 90.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 23.6.

Resonance Health Limited's total revenue rose by 9.5% to $2M since the same quarter in the previous year.

Its net income has increased by 168.6% to $770K since the same quarter in the previous year.

Finally, its free cash flow grew by 413.5% to $531K since the same quarter in the previous year.

Based on the above factors, Resonance Health Limited gets an overall score of 4/5.